The cholesteatoma phenotype: pathology, etiology, and epidemiology
Cholesteatoma (in the middle ear) is a tumor of the middle ear cavity, comprising onion peel-like layers of keratinizing squamous epithelial cells, thus forming an epidermoid cyst. It usually grows slowly but with local invasion. Destruction is caused by osteoclastic resorption in surrounding bone and auditory ossicles. Its growth is not actively invasive like a malignant tumor, spreading no metastasis and demonstrating no neoplasms; therefore, cholesteatoma is neither a tumor nor cancerous.
In modern otology, cholesteatoma can be defined as "chronic osteoclastic bone resorption following foreign, keratinizing squamous epithelium in the middle ear cavity, which usually only has a mucous membrane lining, with serious risk of complications". Chronic bone purulence is triggered by bacterial superinfection. As part of our work in Bielefeld, we asked the question whether this infection could not also be the cause of cholesteatoma development, as can be followed in this article.
The incidence of cholesteatomas in the Caucasian population is 3/100,000 children and 9/100,000 adults. There is a significant preponderance among males (occurring 1.4 times more frequently than in females), and Caucasians. Its occurrence among Inuit Eskimos is seen considerably more rarely, probably because this ethnic group demonstrates an enlarged nasopharynx. It may be that this enlargement permits simpler middle ear aeration, thus helping to prevent chronic ear disease.
The cholesteatoma phenotype: tympanic cavity, clinical pathogenesis und appearance
The human tympanic cavity is approximately 12-15 mm long and 3-7 mm wide. Its internal volume is small, totalling circa only 1 cm 3 . It comprises three sections: the epitympanic recess, the mesotympanum, and the hypotympanum.
According to their pathogenesis, a distinction is made between two forms of this aggressive form of middle ear infection: Congenital cholesteatoma usually presents in patients during early childhood behind an intact ear drum in an anterosuperior location (mesotympanum). This form is rare (1%-3% of all middle ear cholesteatomas) and was first described by Derlacki and Clemis in 1965. Acquired cholesteatoma usually occurs in adults at a posterosuperior location of the tympanic membrane, perforating in the region of the pars flaccida (Shrapnell's membrane). Congenital cholesteatomas are rare and should fulfil the following criteria to be described as such: F Intact tympanic membrane F No previous ear surgery or trauma F Normal middle ear mucous membrane F No recurrent middle ear infections Given its significantly lower incidence, by "cholesteatoma" we will always refer to the e-Neuroforum · 200 | acquired form here, unless otherwise indicated. Both forms can be distinguished on the basis of their telomere length using molecular biological techniques: telomerase activity in the cells of congenital cholesteatoma is low, thus the telomeres appear shortened, while the length of telomeres in cells in acquired cholesteatoma is almost identical to that of telomere length in auditory canal cells.
In 1993, Tos undertook a new classification of cholesteatomas, whereby he concentrated predominantly on the localisation of the process and its surgical classification. Unclear retraction of the pars flaccida (thin part of the tympanic membrane) he defined as "attic cholesteatoma", which extends to the attic or aditus and possibly also to the antrum, mastoid process, or middle ear cavity. He defined posterosuperior retraction or perforation of the pars tensa, extending to the sinus tympanicus, the posterior part of the tympanic membrane, or further as sinus cholesteatoma. He used tensa cholesteatoma to refer to retraction or adhesion of the entire pars tensa (taut part of the tympanic membrane), including the tympanic orifice of the eustachian tube. Tensa cholesteatoma, however, can extend further into the attic cavity (Excursus 1).
Chronic middle ear inflammation generally presents clinically as worsening conductive hearing loss. The inflammation is usually associated with chronic bone purulence. If untreated, this can lead to osteoclast activation and subsequently to the loss of individual or all auditory ossicles, ultimately resulting in hearing loss (. Fig. a) . The middle ear (. Fig. b) has the most critical structure-function relationship in the human body: the loss of 1 mg bone from the ossicle chain can result in a functional loss in auditory impression of up to 50%. In humans, the malleus (hammer) weighs 23 mg, the incus (anvil) 27 mg, and the stapes (stirrup) 2.5 mg (weights may vary slightly). The auditory ossicles are linked together in an articulated manner, attached by a ligamentous apparatus in the middle ear cavity and covered entirely by middle ear mucous membrane.
Once progression has started, patients with cholesteatoma can suffer other complications such as a sensation of pressure in the ear, tinnitus, deafness, dizziness, meningitis, or brain abscess (. Fig. 2c ), making surgical removal necessary (. Fig. 2d) .
Cholesteatomas can have very distinct appearances on ear microscopy, ranging from a white "pearl" (. Fig. 2a) , which shines through the intact tympanic membrane (in the case of primary cholesteatoma), or unclearly defined pockets to scaly, marginal tympanic membrane perforation (. Fig. 2b ). Secondary cholesteatomas are generally associated with foetid muco-purulent otorrhea.
How does a cholesteatoma form?
Cholesteatomas form as a result of squamous cell migration to the middle ear (tympanic cavity), which is sterile under physiological conditions. In a normal, healthy human, the tympanic cavity is coated with a single-layered flat or cuboid respiratory epithelium. When (keratinizing) squamous epithelium (from the external auditory canal, e.g., due to metaplasia or dislocation of embryonal mesenchymal remnants, see Excursus 1) gets into middle ear cavity, uncontrolled -and as yet unexplained -cell growth begins. The newly formed "pearl" comprising stratified onion skin-like keratinizing squamous epithelium cells continues to grow, forming a cholesteatoma matrix. This matrix is distinct from the cholesteatoma perimatrix, which consists of subepithelial connective tissue (. Fig. 2e) .
A chronic inflammatory reaction occurs in the region of the perimatrix. This inflammation can result in osteoclastic resorption, particularly of the auditory ossicles and the neighbouring petrous bone structures.
There are several theories on the development of congenital cholesteatoma: epithelial cell migration through the intact tympanic membrane, metaplasia, embry- onic bacterial dislocation, as well as persistent epidermoid formation.
In the case of acquired cholesteatoma, ingrowth of squamous epithelium through a primary defect or retraction pocket that is no longer self-cleaning is often observed. Theories on its genesis include metaplasia, immigration of squamous epithelium through a marginal tympanic membrane defect, the retraction pocket hypothesis, hyperplasia of the basal cell layer or a combination of retraction and hyperplasia (see Excursus 1) .
The question is, however: what is the initial cause of this migration and proliferation of squamous epithelial cells?
Where and when do middle ear cholesteatomas initially occur?
We shall begin with a brief historical outline and follow on to current work on the subject of cholesteatoma development. In 1936, Teed observed horny, epidermal cells showing keratinization and exfoliation at the posterior upper pole of the tympanic cavity in a 4-month-old fetus and suspected that the persistence of these cells could cause cholesteatoma. In 1982, after five decades of very scant research activity into the etiology of cholesteatoma, these epidermoid formations (EFs) were once again defined as "cell islets of keratinizing squamous epithelium" in 42% of foetuses examined by Leslie Michaels et al. [4] in London. The EFs were regularly identified in the anterosuperior section of the side wall of the tympanic cavity, near the tympanic membrane. By a mechanism as yet unexplained, this tissue disappears during the first years of life. The EFs form in the 16 th gestational week arising from the epidermis of the auditory canal. If they fail to regress, EFs can be considered the starting point for the development of congenital cholesteatoma. An EF consists of a thick layer of stratified and flat cells and is to a certain extent associated with keratin build-up. However, the majority of EFs display no tendency to keratinize. In immunohistochemical tests two decades later, Michals et al. were able to show a distribution pattern of cytokeratins similar to that of the external auditory canal epithelium.
By analysing the expression of proteins in tissue from congenital and acquired cholesteatomas, our working group was also able to identify an identical pattern of various cytokeratins. This indicates that both forms could derive from a common origin (Olzewska et al. 2005 ). In particular, cytokeratin (CK) 10 and CK 34bE12 (detects CK1, 5, 10, 14) antibody staining in keratinizing epithelium points to increased growth capacity in both types of cholesteatoma. In the absence of a suitable animal model, it is not yet possible to observe whether such an (e.g. EGFP-tagged) area of EF could be identified later in an adult (cholesteatoma). It would be of great interest to discover why EFs simply disappear in over 50% of patients examined and not in others.
We already started our research into the expression patterns of cytokeratins in keratinocytes several years ago. Interestingly, we noticed that these keratinizing cells, which form more than 90% of skin, do not react to signals from inflamed stroma (see below). On comparing their cytokeratin expression pattern to neighbouring ear epithelia (middle ear mucous membrane, auditory canal epithelium, glandular epithelium), we observed a specific pattern in the combination of anti-CK4, -CK34βE12, -CK10, -CK14 antibodies for the hyperproliferation of cholesteatoma epithelia, not, however, for the other normal tissues.
Inspired by the earlier research carried out at the ENT center in Großhad-ern, Germany, by Professor Kastenmeier and Dr. Bujia into the immune system in cholesteatoma patients, we wanted to find out what causes hyperproliferative growth and differentiation pattern changes in keratinocytes. To this end, we analysed middle ear mucosa using immunohistochemical methods. In a normal ear, the middle ear drum is lined with a secretory cuboid or cylindrical mucosa, which covers a thin mesenchymal layer. In the presence of a cholesteatoma, this mucosa is replaced by immigrating keratinizing squamous epithelium. The mucosa remains present as a cystic formation in the cholesteatoma stroma or becomes attached to the migrating front of the cholesteatoma epithelium.
Middle ear cholesteatoma. A pathway to investigate the underlying mechanisms of the aggressive variant of chronic otitis media Abstract
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Which factors influence middle ear cholesteatoma the most?
By means of immunohistochemical analysis and in situ hybridisation, we found that there were high concentrations of lymphocytes and macrophages in the stroma of reactive cholesteatoma epithelium and non-reactive middle ear mucosa. These immune cells expressed IL (interleukin)-1, tumor growth factor (TGG)-α, epidermal growth factor (EGF), and epidermal growth factor receptor (EGFR). The receptor was upregulated in cholesteatoma epithelium, confirming the autocrine loop theory: the keratinocytes are activated and then proliferated and migrated by the factors. We also observed an expansion in EGFR expression from basal cell levels (proper auditory canal epithelium) to suprabasal cells (cholesteatoma). Furthermore, the proportion of EGFR-mRNA expressed cells in epithelial cells had risen from 10% to 75%. In addition, a reduced concentration of IL-1 receptor antagonists (IL-1R-A) lead to increased biological activity in the existing IL-1 [2] . The mucosa, however, showed no reaction to anti-EGFR polyclonal antibodies. Middle ear mucosa derives phylogenetically from endoderm, while squamous epithelium derives from the ectoderm.
The keratinocytes in middle ear mucosa therefore appear not to react to stimuli from the inflamed stromal tissue. Further experiments are needed to understand the differences in behaviour between mucosa and squamous epithelium under the influence of inflamed connective tissue.
What leads to increased proliferation of cholesteatomas?
We were able to prove that the active cell reproduction rate in cholesteatoma keratinocytes is significantly increased [6] . Our investigations using cell-cycle associated nuclear antigens (MIB-1) showed not only that the proliferation index (quotient of MIB-1 positive cells to the overall number of cells) for keratinocytes in cholesteatoma is 2.3-fold higher than in keratinocytes in normal auditory canal epidermis (17.4% vs. 7.6%), but also that there are evidently different stages of proliferation in cholesteatoma tissue, as supported by both the broad-ranging index (9.5%-41%) among samples examined and the observation of markedly varying quotients in different regions of the same cholesteatoma tissue. 
Review article
The average number of MIB-1-positive keratinocytes rose according to epidermal thickness. Jesus Bujia suggested two possible explanations for this behaviour: either a keratinocyte proliferation disorder was occurring, which was then being supported by autocrine growth stimulation of the cholesteatoma epithelium, or the inflammation was leading to an increase in epithelial renewal, as indicated by the numerous MIB-1-positive keratinocytes in the basal-cell layer.
Steinbach attempted to develop an inducible animal model for the cholesteatoma. In his tests on rabbits, he noticed that cholesteatomas initially develop squamous epithelium coni, which are later separated into subepithelial connective tissue. In our human samples, we also observed these growth coni with significantly increased immune staining for MIB-1 in the keratinocytes. The subepithelial connective tissue in particular revealed a series of local proliferation activities of varying strength.
Ki-67 staining, induced by MIB-1, can be found in the nuclei and cytoplasm of basal keratinocytes in normal human skin. The number of Ki-67-positive cells increases in the basal layers of cholesteatoma tissue; in addition, large amounts of cells can be found in the suprabasal layers (compared to skin by factor 1.3 and 1.2 in bacterially infected and non-infected cholesteatomas, respectively).nterestingly, no direct correlation to Ki-67 could be found using yet another proliferation marker. The broad range of heterogeneity of cell staining using proliferating cell nucleus antigen (PCNA) in the different layers of the cholesteatoma is similar in PC-NA-positive cells to Ki-67 staining, but not identical. The difference lies in the fact that PCNA staining is only possible in nuclei currently in the S phase, while with Ki-67 even cells in the M, G2, or later G1 phase are marked. In normal tissue, PC-NA-positive cells are found near the basal lamina, while in cholesteatoma epithelium the suprabasal cell layers are stained. This can be seen as an indication that increased cell division in the upper layers of the epidermis is responsible for the increase in thickness of the cholesteatoma epithelium. Interestingly, PCNA staining is of varying intensity in different areas irrespective of epithelial thickness. In addition, no differences were observed between inflamed and non-inflamed cholesteatomas in terms of PCNA staining, meaning that the hyperproliferative behaviour of the epithelium in cholesteatomas is possibly caused by cytokines and growth factors released by immunologically active connective tissue cells.
Who or what causes this immune cell activation? To answer this question, we will look at the morphological changes in the original squamous epithelium.
What changes morphologically in the cholesteatoma as a result of growth?
The cholesteatoma matrix demonstrates a tendency towards active papillary ingrowth into the subepithelial connective tissue. Additionally, the matrix distinguishes itself as hyperproliferating epithelial tissue, while the distribution of maturing keratinocytes within the matrix is inhomogeneous.
In addition to the clear parallels with response patterns in wound healing, we find increased expression of matrix metalloproteinases MMP1, 2, and 3 in the perimatrix, as well as reduced expression of tissue inhibitors of metalloproteinases (TIMPs). In this way, proteolytic activity in the perimatrix is significantly increased.
A comparison of immune reactivities for collagen type IV and VII as well as fibronectin in the basal lamina of the skin showed that collagen reactivities in cholesteatoma tissue had disappeared, while fibronectin in the extrinsic basal lamina and subepithelial connective tissue appeared to be highly upregulated. Ultrastructural observations showed that the basal lamina of the cholesteatomas resembles that of skin, and that there are abnormal changes in the lamina fibroreticularis et densa (. Fig. a) . These observations suggested that cholesteatoma represents a disease with altered cell matrix interactions, which evoke re-epithelialization following injury.
The proliferating cells also need to be supplied and nourished: in collaboration with Allen Ryan from La Jolla we counted the blood vessels in the tissues and noticed that a between 3.2-fold (compared with middle ear mucosa) and 4-fold (compared with actual auditory canal epidermis) rise in capillary vessels could be observed in the perimatrix of the cholesteatoma. The degree of neovascularization -as demonstrated by the expression pattern of fibroblast growth factor 2 (FGF2), vascular epithelial growth factor (VEGF), TGF-β1 and -α -also rose 4.3-and 2-fold, respectively (. Fig. b; [3] ).
In a further study, it was possible to show that immune reactivity for collagen IV (a network-forming collagen) in normal skin and middle ear mucosa in the region of the basal membrane zone (BMZ) is continuous, while in cholesteatomas it appears to be absent or heavily interrupted. Collagen VII (anchoring fibrils), however, appears to be continuously expressed. To date, 28 different collagen types are known (types I-XXVIII). All collagens have in common the fact that they are formed from three polypeptide chains, known as collagen helices, and have the form of a twined triple helix.
The immune reactivity for fibronectin (an extracellular glycoprotein which plays an important role in many physiological processes, including tissue repair, embryogenesis, hemostasis, as well as in cell migration and adhesion), however, is stronger in cholesteatomas (external BMZ, subepithelial connective tissue). The ultrastructure of the cholesteatoma has the characteristics of a disease with destroyed cell matrix interaction, e.g., re-epithelialization following skin injury. Extensive changes are particularly visible in the lamina fibroreticularis (part of the skin) und lamina densa (part of the BMZ).
Albino et al. demonstrated that even in mast cells a three-to seven-fold increase in congenital and acquired cholesteatoma compared with normal tissue (tympanic membrane, auditory canal skin, postauricular skin) can be detected. In all, 19%-34% of these cells were found in the suprabasal layers of the squamous epithelium, which can also be found in severely inflamed, but not mildly inflamed, tympanic membranes. The mast cells are heavily involved in the case of inflammation in particular, defence against bacteria, the induction of skin tissue renewal, as well as strengthening angiogenesis.
From this observation and knowledge that mast cells secrete numerous factors (e.g., bFGF, IL-1, -3, -4, -5, -6, -8, GM-CSF, IFN-γ, TNFα, TGFb1, macrophage inflammatory protein 1a, and RANTES), we can draw two conclusions: cholesteatoma induction is possibly the result of an impaired wound healing process with significant changes within the cholesteatoma epithelium; or induction occurs as a result of a pathological collision between the inflammatory response, the normal middle ear epithelium, and an acute bacterial infection.
Since no increase in the number of mast cells is observed in the dry auditory canal of the Caucasian ear with scant bacteria and inflammatory responses, we must assume that wound healing without inflammatory responses is insufficient to induce mast cell migration. A similar observation was made in otitis media, i.e., that mast cells activate and mediate the innate immune defense system to defend against bacterial infections in the middle ear.
On the other hand, the acquired immune defense system may also be involved, as shown recently by a Polish research group: the Toll-like receptors TLR-2, -3, and -4 are more strongly expressed in auditory canal skin than in the epithelium of the cholesteatoma (and partially also in the perimatrix).
We now turn to microbial and fungal life in the auditory canal -the middle ear itself is sterile under normal conditions.
Could bacteria in the auditory canal be a cause of cholesteatoma development?
Under physiological conditions, Staphylococcus epidermidis, Corynebacterium spp., Micrococcus spp., α-hemolytic und non-hemolytic streptococci, as well as small numbers of Pseudomonas aeruginosa and S. aureus live in the human auditory canal. In a healthy ear, the squamous epithelium of the external auditory canal and the mucosal epithelium of the middle ear are separated by the tympanic membrane. The pathogens most commonly responsible for middle ear inflammation, Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis, are not usually found in the auditory canal under normal circumstances. S. aure- us and P. aeruginosa are found in chronically inflamed, suppurating ears.
Normal middle ear mucosa in humans is only a few micrometers thick and comprises scant inflammatory cells. In the case of middle ear inflammation, this cell layer increases by some hundred micrometers, comprising numerous inflammatory cells and new microvessels. In human cholesteatomas, increased concentrations of mast cells are found. In addition to cytokines, these cells secrete large numbers of proteinases, such as tryptase, chymase, carboxypeptidase, and cathepsin G. The mast cell granules contain mitogen and angiogenic factors, such as bFGF, IL-6, and -8, which are also responsible for neovascularization in cholesteatoma tissue.
The fluid secretion of human apocrine glands appears at first to be sterile on the skin surface. It contains pheromones and components of the innate immune defense system, such as lactoferrin, lysozyme, and defensins. Maturation of the secretory elements in the tympanic tubes takes until postnatal day 21 in mice. Cerumen appears to play an important role in defense against bacterial infection (e.g., Staphylococcus epidermidis, Corynebacterium spp., Candida albicans) in the external auditory canal.
Our latest investigations relate to the presence of so-called antimicrobial peptides (. Fig. ) , which are also a component of the cerumen. We hope to elucidate in which way they contribute to immune defense against bacterial infection and the possible resultant cause of cholesteatomas. As an important part of the innate immune system, they have a broad microbial, fungicidal, and antiviral potency. Some of the 900 peptides identified to date in humans and animals are ascribed other properties, such as bacteriolysis, opsonization, immuno-potentialization, and antitumor activities. In addition to these characteristics, β-defensins, for example, also bind and modulate the congenital with the acquired immune response by means of their function as chemo-attractors for immature dendritic cells, T-lymphocytes, and mast cells.
The presence of bacterially infected and non-bacterially infected cholesteatomas may present a further problem. The role of a biofilm infection in the cholesteatoma needs to be clarified in the future. Biofilm-forming bacteria, such as Pseudomonas aeruginosa, which are enclosed in an extracellular polymer matrix, can accumulate at the boundary of the desquamated keratin. Biofilm-forming bacteria are less susceptible to the human immune defense system, as a result of which a biofilm-associated infection can develop over a long period of time and contribute to the pathogenesis of middle ear cholesteatoma.
Results and perspectives
A cholesteatoma can be considered as misguided wound healing of the external auditory canal skin. Human petrous bone studies have shown that, even in an intact tympanic membrane, former retractions can leave squamous epithelium nests at their former attachment sites and lead to cholesteatomas. We are currently concentrating on the analysis of bacterial causes due to possible defects in the congenital immune defense system. This innate immune defense system is to a great extent inducible, which could lead to the development of new drugs. At present, the only form of therapy for cholesteatomas is surgical removal. (. Fig. 5) The development of middle ear cholesteatomas: theories and locations (1) Metaplasia: Triggered by inflammation, the existing epithelium of the tympanic mucosa transforms into a squamous epithelium (currently a point of discussion).
Excursus 1
(2) Immigration: As a result of tympanic membrane perforation [e.g., inflammatory (measles otitis), traumatic, or mechanical] squamous epithelium grows into the middle ear. This epithelium shows a significant growth tendency depending on the chronic inflammatory stimulus of the perimatrix, which in turn provokes invasive basal cell hyperplasia of the squamous epithelium, encapsulates itself, and so forms the cholesteatoma.
(3) Retraction pockets: Impaired aeration of the eustachian tube leads to invagination of the tympanic membrane due the negative pressure caused. Keratinocytes are deposited here, which then travel through the retraction into the tympanic cavity, transported usually by the pars flaccida, since the tympanic membrane is held together at this point and pressure appears to be at its lowest.
(4) Hyperplasia of the basal cell layer: As a result of sporadic papillary ingrowth of squamous epithelial cells on the outer surface of the tympanic membrane, filled epidermal cysts are formed that develop into cholesteatomas.
(5) A combination of (3) and (4). (c) Pars tensa retraction cholesteatoma arises from the pars tensa as an adhesive process, or from a larger perforation with possible extension into the eustachian tube orifice and the epitympanum.
Cholesteatomas: surgical classification
(d) A special form of cholesteatoma, epidermosis, in which epithelium grows laminally on the inner surface of the tympanic membrane. As in the case of a peripheral defect, the epithelium then grows directly onto the bone. The special feature of this form lies in the laminar growth.
Excursus 2

Cytokeratins
Prior to keratinization, as well as generally in the epithelia of vertebrates and other animal groups, cytokeratins (or α-keratins) are present in the form of loosely organized keratin filaments. These belong to the intermediary filaments that, together with the microtubules and microfilaments (F-actins), form the cytoskeleton of eukaryotic cells. At present, 20 different cytokeratin proteins are known (see below); with molecular masses ranging between 40 and 68 kDa, they represent the largest class of intermediary filaments. They have isoelectric points between pH 5 and 8 and usually occur in pairs in epithelial cells. CK1-CK8 belong to the neutralbasic type A subfamily, while CK9-CK20 belong to the acidic type B subfamily. In pairs, these form a heterodimer complex in the intermediary filaments comprising one type A and one type B cytokeratin. Cytokeratins have a central rodshaped, α-helical domain with hypervariable regions rich in serine and glycine sequences. Acidic cytokeratins of relatively low molecular weight bind to a basic cytokeratin of relatively high weight (approximately 7-10 kDa difference).
The distribution pattern of these complexes varies significantly in the individual epithelial cells, such that detection of anti-CK1-CK20 subtypes (. Tab. ) makes it possible to identify the origin of these cells. This technique is used in histopathological diagnosis to determine the origin of tumor metastases.
